The complexity of issues relating to cell manufacturing, the underlying regulatory framework, reimbursement and viable business models all represent challenges that severely undermine the timing and the delivery of a sustainable healthcare model. Our programme will equip you with the knowledge that will enhance the understanding of these complex issues within an integrated and commercial context.
This one-year advanced study course explores the biological, regulatory and business aspects of cellular therapy in the fields of biomedicine. The course also includes a dissertation related to business strategy development for cellular therapy.
You will study modules totalling 180 credits throughout the year, with 45 credits coming from the 15,000 – 18,000 word dissertation. The majority of learning for this degree takes place at the King’s College London Guy’s campus. Some of the lectures are also delivered at the Demark Hill and Waterloo campuses; please note that locations are determined according to where each module is taught.